Lode Resources Ltd (ASX:LDR)

Verve Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	4.58	2.28	4.85	2.18	4.74	0.3
Cash & Short-Term Investments	4.58	2.28	4.85	2.18	4.74	0.3
Cash Growth	41.82%	-53.01%	122.19%	-53.98%	1484.56%	-
Other Receivables	-	0.02	0.09	0.08	0.04	0
Receivables	0.09	0.02	0.09	0.08	0.04	0
Other Current Assets	-	-	0	0	0	-
Total Current Assets	4.67	2.3	4.94	2.26	4.78	0.3
Property, Plant & Equipment	7.15	5.2	4.17	2.19	0.36	0.03
Other Long-Term Assets	1.28	0.47	0.4	0.17	0.1	0.02
Total Assets	13.09	7.96	9.51	4.62	5.24	0.35
Accounts Payable	0.11	0.03	0.46	0.3	0.08	0.01
Accrued Expenses	0.08	0.07	0.04	0.03	-	-
Current Portion of Leases	0.02	0.04	0	0.03	-	-
Other Current Liabilities	-	0.05	0.12	0.07	0.06	-
Total Current Liabilities	0.21	0.18	0.62	0.44	0.14	0.01
Long-Term Leases	-	0	-	0	-	-
Total Liabilities	0.84	0.18	0.62	0.44	0.14	0.01
Common Stock	14.34	9.11	9.11	5.61	5.61	0.37
Additional Paid-In Capital	0.75	2.39	2.47	0.14	0.09	-
Retained Earnings	-2.83	-3.72	-2.68	-1.57	-0.6	-0.02
Shareholders' Equity	12.26	7.78	8.9	4.18	5.1	0.34
Total Liabilities & Equity	13.09	7.96	9.51	4.62	5.24	0.35
Total Debt	0.02	0.04	0	0.04	-	-
Net Cash (Debt)	4.56	2.24	4.84	2.15	4.74	0.3
Net Cash Growth	43.55%	-53.76%	125.72%	-54.72%	1484.56%	-
Net Cash Per Share	0.04	0.02	0.05	0.03	0.09	0.03
Filing Date Shares Outstanding	161.78	106.78	106.78	79.97	79.97	46.46
Total Common Shares Outstanding	161.78	106.78	106.78	79.97	79.97	46.46
Working Capital	4.46	2.12	4.33	1.82	4.64	0.29
Book Value Per Share	0.08	0.07	0.08	0.05	0.06	0.01
Tangible Book Value	12.26	7.78	8.9	4.18	5.1	0.34
Tangible Book Value Per Share	0.08	0.07	0.08	0.05	0.06	0.01
Machinery	-	-	-	0.04	0.03	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.